1. Home
  2. XLO vs HUIZ Comparison

XLO vs HUIZ Comparison

Compare XLO & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • HUIZ
  • Stock Information
  • Founded
  • XLO 2016
  • HUIZ 2006
  • Country
  • XLO United States
  • HUIZ China
  • Employees
  • XLO N/A
  • HUIZ N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • HUIZ Specialty Insurers
  • Sector
  • XLO Health Care
  • HUIZ Finance
  • Exchange
  • XLO Nasdaq
  • HUIZ Nasdaq
  • Market Cap
  • XLO 37.9M
  • HUIZ 33.3M
  • IPO Year
  • XLO 2021
  • HUIZ 2020
  • Fundamental
  • Price
  • XLO $0.80
  • HUIZ $3.29
  • Analyst Decision
  • XLO Buy
  • HUIZ
  • Analyst Count
  • XLO 1
  • HUIZ 0
  • Target Price
  • XLO $4.00
  • HUIZ N/A
  • AVG Volume (30 Days)
  • XLO 2.7M
  • HUIZ 32.1K
  • Earning Date
  • XLO 03-11-2025
  • HUIZ 03-24-2025
  • Dividend Yield
  • XLO N/A
  • HUIZ N/A
  • EPS Growth
  • XLO N/A
  • HUIZ N/A
  • EPS
  • XLO N/A
  • HUIZ 0.29
  • Revenue
  • XLO $6,344,000.00
  • HUIZ $170,927,079.00
  • Revenue This Year
  • XLO $707.71
  • HUIZ N/A
  • Revenue Next Year
  • XLO $26.48
  • HUIZ $10.46
  • P/E Ratio
  • XLO N/A
  • HUIZ $11.20
  • Revenue Growth
  • XLO N/A
  • HUIZ N/A
  • 52 Week Low
  • XLO $0.58
  • HUIZ $2.15
  • 52 Week High
  • XLO $1.93
  • HUIZ $10.58
  • Technical
  • Relative Strength Index (RSI)
  • XLO 43.56
  • HUIZ 46.08
  • Support Level
  • XLO $0.73
  • HUIZ $3.00
  • Resistance Level
  • XLO $0.98
  • HUIZ $3.65
  • Average True Range (ATR)
  • XLO 0.10
  • HUIZ 0.37
  • MACD
  • XLO -0.02
  • HUIZ -0.04
  • Stochastic Oscillator
  • XLO 23.26
  • HUIZ 16.07

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: